Search Within

Teresa Wasielewska

Formats
  1. Meeting Abstract (12)
  2. Journal Article (5)
Groups
  1. Department of Medicine (17)
  2. Hematologic Malignancies, Division of (17)
  3. Center for Hematologic Malignancies (15)
  4. GSK Faculty (15)
  5. Hematologic Malignancies Research (13)
  6. Molecular Pharmacology and Chemistry Program Faculty (13)

More Groups

People
  1. Isabelle Riviere (15)
  2. Michel Sadelain (13)
  3. Xiuyan Wang (13)
  4. Jinrong Qu (11)
  5. Jolanta Stefanski (10)
  6. Shirley Bartido (10)

More People

Years
  1. 2018 (2)
  2. 2016 (1)
  3. 2015 (2)
  4. 2014 (2)
  5. 2013 (4)
  6. 2012 (5)

More Years

Publications
  1. Molecular Therapy (5)
  2. Blood (4)
  3. Human Gene Therapy (2)
  4. Science Translational Medicine (2)
  5. Cancer Research (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. Nature Publishing Group (5)
  2. American Society of Hematology (4)
  3. American Association for the Advancement of Science (3)
  4. Mary Ann Liebert, Inc (2)
  5. American Association for Cancer Research (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia
    Journal Article

    Brentjens, R. J.; Davila, M. L.; Riviere, I.; Park, J.; Wang, X.; Cowell, L. G.; Bartido, S.; Stefanski, J.; Taylor, C.; Olszewska, M.; more...
    Science Translational Medicine (2013)

    Fulltext@MSK | Save
  • A phase I clinical trial of autologous, anti-CD19 gene targeted T cells for adults with B cell acute lymphoblastic leukemia (B-ALL)
    Meeting Abstract

    Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Stefanski, J.; Taylor, C.; Olszewska, M.; Borquez-Ojeda, O.; Qu, J.; Wasielewska, T.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Impact of the conditioning chemotherapy on outcomes in adoptive T cell therapy: Results from a phase I clinical trial of autologous CD19-targeted T cells for patients with relapsed CLL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Stefanski, J.; He, Q.; Taylor, C.; Olszewska, M.; Wasielewska, T.; Bartido, S.; Davila, M. L.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Molecular remission and B cell aplasia induced in a first cohort of adults with relapsed B-ALL treated with 19-28z CAR-targeted T cells
    Meeting Abstract

    Davila, M. L.; Riviere, I.; Wang, X. Y.; Park, J. H.; Stefanski, J.; Taylor, C.; He, Q.; Olszewska, M.; Wasielewska, T.; Borquez-Ojeda, O.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Targeting castration resistant prostate cancer (CRPC) with autologous PSMA-directed chimeric antigen receptor T cells
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Borquez-Ojeda, O.; Stefanski, J.; Olszewska, M.; Taylor, C.; Wasielewska, T.; Bartido, S.; Poon, S.; Scher, H. I.; more...
    Molecular Therapy (2012)

    Fulltext@MSK | Save
  • ARN-509: A novel antiandrogen for prostate cancer treatment
    Journal Article

    Clegg, N. J.; Wongvipat, J.; Joseph, J. D.; Tran, C.; Ouk, S.; Dilhas, A.; Chen, Y.; Grillot, K.; Bischoff, E. D.; Cai, L.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Development of a second-generation antiandrogen for treatment of advanced prostate cancer
    Journal Article

    Tran, C.; Ouk, S.; Clegg, N. J.; Chen, Y.; Watson, P. A.; Arora, V.; Wongvipat, J.; Smith-Jones, P. M.; Yoo, D.; Kwon, A.; more...
    Science (2009)

    Fulltext@MSK | Save